NCT03626064

Brief Summary

The PROMPT Pilot Study is a feasibility mixed methods prospective cohort study following principles of community-based participatory action research. The study recruited 80 people who use drugs and followed them for 6 months while providing access to counselling, nicotine replacement therapy and peer-support in a community setting. A notable reduction in average cigarette use per day (20.5 to 9.3) and illicit substance use (18.8%) was observed at study-end. PROMPT's patient engagement model is an effective harm-reduction strategy for the growing opioid use crisis and can improve the health outcomes of marginalised at-risk populations worldwide.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2014

Typical duration for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2014

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2017

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

June 11, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 10, 2018

Completed
Last Updated

March 29, 2023

Status Verified

August 1, 2018

Enrollment Period

2.8 years

First QC Date

June 11, 2018

Last Update Submit

March 28, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Retention of Study Participants

    Retention rate at 6-month follow-up

    6 months

Secondary Outcomes (1)

  • Biochemical Validation of Smoking Cessation Outcome

    6 months

Study Arms (1)

PROMPT Participants

OTHER

80 participants who are homeless or at-risk for homelessness, smoke tobacco, and identify as People Who Use Drugs in Ottawa.

Behavioral: Smoking Cessation CounsellingDrug: Nicotine Replacement Therapy

Interventions

One on one smoking cessation counselling with a certified mental health nurse

PROMPT Participants

Access to a range of nicotine replacement therapy: nicotine patch, nicotine gum, nicotine lozenge, nicotine inhaler

PROMPT Participants

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • currently living in Ottawa for at least 3 months prior to enrolment
  • years or older
  • have used drugs in the past year (excluding marijuana and alcohol)
  • have smoked tobacco in the past 7 days

You may not qualify if:

  • consent declined (refusal from participant or decision maker)
  • any person accessing addictions treatment (in-patient drug rehabilitation) and hence unavailable for follow-up
  • any person currently or recently (in the past 30 days) enrolled in a smoking cessation program
  • anyone with a terminal illness with a life expectancy of \<3 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (2)

  • Pakhale S, Visentin C, Tariq S, Kaur T, Florence K, Bignell T, Jama S, Huynh N, Boyd R, Haddad J, Alvarez GG. Lung disease burden assessment by oscillometry in a systematically disadvantaged urban population experiencing homelessness or at-risk for homelessness in Ottawa, Canada from a prospective observational study. BMC Pulm Med. 2022 Jun 16;22(1):235. doi: 10.1186/s12890-022-02030-x.

  • Pakhale S, Tariq S, Huynh N, Jama S, Kaur T, Charron C, Florence K, Nur F, Bustamante-Bawagan ME, Bignell T, Boyd R, Haddad J, Kendzerska T, Alvarez G. Prevalence and burden of obstructive lung disease in the urban poor population of Ottawa, Canada: a community-based mixed-method, observational study. BMC Public Health. 2021 Jan 21;21(1):183. doi: 10.1186/s12889-021-10209-w.

MeSH Terms

Conditions

Tobacco Use DisorderTobacco Use Cessation

Interventions

Nicotine Replacement Therapy

Condition Hierarchy (Ancestors)

Substance-Related DisordersChemically-Induced DisordersMental DisordersHealth BehaviorBehavior

Intervention Hierarchy (Ancestors)

Drug TherapyTherapeutics

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 11, 2018

First Posted

August 10, 2018

Study Start

June 1, 2014

Primary Completion

March 1, 2017

Study Completion

March 1, 2017

Last Updated

March 29, 2023

Record last verified: 2018-08

Data Sharing

IPD Sharing
Will share

Data will be available to researchers that contact the Principal Investigator.

Shared Documents
SAP
Time Frame
Data will be available upon request for the period decided necessary by the Principal Investigator and the inquiring researcher or researchers.
Access Criteria
Will provide access in the manner decided by Principal Investigator and the inquiring researcher or researchers.